Renal cell carcinoma

There are 79 papers on renal cell carcinoma in aging research: 2 trials and 51 observational studies in people, 5 in animals, 2 in cells, 17 reviews. The newest story, Nov 2, 2026: “Low oxygen linked to cancer-related mutations in human kidney cells”.

Disease

79 papers study it46 more mention it16 findings

7 new papers in 30 daysSee all 125 papers on renal cell carcinoma

“ANGPTL3 inhibition was also associated with an increased risk of renal cell carcinoma (OR =1.975; 95% CI: 1.217-3.205)”
The role of lipid-lowering drugs in urologic and male reproductive cancers: a Mendelian randomization studyTranslational andrology and urology2026doi:10.21037/tau-2026-1-0146
  • Human trial2
  • Humans51
  • Animals5
  • Cells2
  • In silico1

Upstream

1

TMEM72

downin human cells1

1 study
  1. TMEM72 protects against renal cell carcinoma in human cells (overexpression).

    Cellsoverexpression

More on TMEM72

Associations

13

Telomere length

upin humans2upin silico1OR 1.96–2.07

3 studies
  1. Telomere length is linked with a higher risk of renal cell carcinoma in humans (OR 2.07, 95% CI 1.70-2.53).

    Humans

  2. Telomere length raises the risk of renal cell carcinoma in silico (OR = 1.96, 95% CI 1.52-2.52).

    In silico

  3. Telomere length is associated with renal cell carcinoma in humans (polygenic score using common variants).

    Reviewpolygenic score using common variants

More on Telomere length

BAP1

upin humans1

1 study
  1. BAP1 is associated with renal cell carcinoma in humans (RR at 80 years 29.9 (95% CI 3.7–50.8); cumulative risk 49.4%).

    HumansHeterozygous germline BAP1 (likely) pathogenic variants; compared with population incidencen = 90

More on BAP1

Vegetable intake

downin humans1

1 study
  1. Vegetable intake is associated with renal cell carcinoma in humans.

    Review

More on Vegetable intake

Smoking

upin humans1

1 study
  1. Smoking is associated with renal cell carcinoma in humans (ever smoking).

    Reviewever smoking

More on Smoking

Obesity

upin humans1

1 study
  1. Obesity is associated with renal cell carcinoma in humans.

    Review

More on Obesity

ANGPTL3

upin humans1OR 1.975

1 study
  1. ANGPTL3 is linked with a higher risk of renal cell carcinoma in humans (genetically proxied inhibition, drug-target Mendelian randomization) (OR 1.975 (95% CI 1.217-3.205)).

    Humansgenetically proxied inhibition, drug-target Mendelian randomization

More on ANGPTL3

SGLT2 inhibitors

downin humans1HR 0.85

1 study
  1. SGLT2 inhibitors are linked with a lower risk of renal cell carcinoma in humans (type 2 diabetes) (HR 0.85, 95% CI 0.79-0.92).

    Humanstype 2 diabetesmean follow-up of 44.2 months

More on SGLT2 inhibitors

eXtreme Gradient Boosting prediction model

upin humans1

1 study
  1. eXtreme Gradient Boosting prediction model predicts renal cell carcinoma in humans (validation cohort) (AUC 0.955 (95% CI: 0.938-0.976); average precision 0.923).

    Humansvalidation cohort

Cellular senescence

upin reviews1

1 study
  1. Cellular senescence is associated with renal cell carcinoma.

    Review

More on Cellular senescence

Metabolically unhealthy obesity

upin humans1HR 2.14

1 study
  1. Metabolically unhealthy obesity is linked with a higher risk of renal cell carcinoma in humans (compared to MHNO) (HR 2.14, 95% CI 1.969-2.325).

    Humanscompared to MHNO

More on Metabolically unhealthy obesity

All 13

Trial sponsors

Funding

4 grants since 2018

National Cancer Institute$1.7MNational Institute of Arthritis and Musculoskeletal and Skin Diseases$576KUS Department of Veterans Affairs

Latest

Dec 2025: 5Jan 2026: 5Feb 2026: 8Mar 2026: 3Apr 2026: 5May 2026: 1Jun 2026: 2Jul 2026: 3Aug 2026: 3Sep 2026: 1Oct 2026: 8Nov 2026: 448 papers in 12 months
bioRxiv

Low oxygen linked to cancer-related mutations in human kidney cells

A distinctive mutation pattern marked 96% of analyzed clear cell kidney cancers.A distinctive mutation pattern marked 96% of analyzed clear cell kidney cancers.

Preprint: human cell studyKidney

See all 125 papers on renal cell carcinoma